1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. CRISPR THERAPEUTICS AG
CRISPR Therapeutics AG XNAS: CRSP

CRISPR Therapeutics AG Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

Read More
55.00 -0.96 (-1.72%)
83.09% Gain from 52W Low
1.6M
XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
9.3 / 100
Momentum Score
Technically Moderately Bullish
62.6 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
81
1Yr Price target upside is 48%
23 analysts

9

S

9

W

4

O

1

T

SWOT Analysis

CRISPR Therapeutics AG Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..